Bojie Dai

1.4k citations
30 papers · 1.1k indexed · h-index 18
Topics
PI3K/AKT/mTOR signaling in cancer (7 papers)Cancer Mechanisms and Therapy (5 papers)Histone Deacetylase Inhibitors Research (5 papers)
Partner nations
United StatesChinaCanada

In The Last Decade

Bojie Dai

29 papers receiving 1.0k citations

Peers

Bojie Dai
Comparison fields: 5 of 84
  • Molecular Biology 697
  • Pulmonary and Respiratory Medicine 264
  • Oncology 194
  • Cancer Research 193
  • Pathology and Forensic Medicine 142
Replace Xuesong Ouyang with:
Xuesong Ouyang United States
Demetra Constantinidou United Kingdom
Qinlian Jiao China
Liangkun You China
Masamitsu Onda Japan
Tiefeng Jin China
Szabolcs Fátrai Netherlands
Timothy G. Whitsett United States
Yu-Mei Feng China
Sunbin Ling China
Bojie Dai relative to Xuesong Ouyang United States Xuesong Ouyang's profile →
Citations per field
00.5×1.5×
Xuesong Ouyang · 1×
Citations per year

Countries citing papers authored by Bojie Dai

Since Specialization
Citations

This map shows the geographic impact of Bojie Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bojie Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bojie Dai more than expected).

Fields of papers citing papers by Bojie Dai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bojie Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bojie Dai. The network helps show where Bojie Dai may publish in the future.

Co-authorship network of co-authors of Bojie Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Bojie Dai. A scholar is included among the top collaborators of Bojie Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bojie Dai. Bojie Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 30
2 13
3 10
4 60
5 12
6 70
7 35
8 50
9 34
10 53
11 23
12 37
13 16
14 12
15 43
16 281
17 38
18 0
19 23
20 2

About Bojie Dai

Bojie Dai is a scholar working on Pathology and Forensic Medicine, Hematology and Immunology, having authored 30 papers that have together received 1.1k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (7 papers), Cancer Mechanisms and Therapy (5 papers) and Histone Deacetylase Inhibitors Research (5 papers). The work is most often cited by research in Cancer Research (193 citations), Geriatrics and Gerontology (44 citations) and Molecular Biology (697 citations). Bojie Dai has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Ronald B. Gartenhaus, Krystyna Mazan-Mamczarz, Yun Qiu, Zhiyong Guo, Kexin Xu, Xiangtian Kong, Hegang Chen, Jonathan Melamed, Oekyung Kim and Tianyun Jiang. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and Genes & Development.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026